Literature DB >> 22165992

Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia.

Jeffrey A Jones, Eric H Kraut, Deidre Deam, John C Byrd, Michael R Grever.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22165992     DOI： 10.3109/10428194.2011.600484

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  Immunoconjugates and new molecular targets in hairy cell leukemia.

Authors:  Robert J Kreitman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 2.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 3.  Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.

Authors:  Prithviraj Bose; Gary L Simmons; Steven Grant
Journal:  Expert Opin Investig Drugs       Date:  2013-05-06       Impact factor: 6.206

Review 4.  Targeting cell cycle regulators in hematologic malignancies.

Authors:  Eiman Aleem; Robert J Arceci
Journal:  Front Cell Dev Biol       Date:  2015-04-09

5.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.